MENU
component-ddb-728x90-v1-01-desktop

Missouri share of Amgen settlement is $603,493

Amgen agreed last month to pay $24.9 million to resolve claims it gave kickbacks to increase sales of its anemia drug Aranesp

Missouri Attorney General Chris Koster says more than $600,000 has been recovered for the Missouri Medicaid program as part of a national settlement against the drug-maker Amgen Inc.



Amgen agreed last month to pay $24.9 million to resolve claims it gave kickbacks to increase sales of its anemia drug Aranesp. Missouri was among several states that accused Amgen of a scheme aimed at inducing nursing home professionals to dispense Aranesp over competing drugs. Missouri's share is $603,493.



Aranesp is one of Amgen's biggest-selling drugs, though sales have fallen sharply since 2007 because of a series of safety problems and restrictions on its use.

In December, Amgen agreed to pay $762 million to resolve federal litigation accusing it of marketing Aranesp for unapproved uses.

Trending